California Passes Flavor Ban: Non-Tobacco Flavored Products Banned

Nov.11.2022
California Passes Flavor Ban: Non-Tobacco Flavored Products Banned
California set to ban flavored tobacco products, including e-cigarettes, with over 62% of votes in favor of Proposition 31.

With over 40% of votes counted, California voters appear poised to approve Proposition 31 by an overwhelming margin, which would prohibit the sale of flavored soda and tobacco products in stores. So far, 62% of voters support the flavor ban.


The financial support for this voting initiative comes almost entirely from billionaire anti-smoking activist Michael Bloomberg.


Proposal 31 allows residents with voting rights to approve or reject a bill passed by the California legislature in 2020 by a significant margin. After a signature campaign funded by tobacco companies submitted the legislation to voters, the law was postponed for two years.


A ban on flavored products, including e-cigarettes, nicotine pouches, and tobacco, will be implemented later this year according to a new law. The law prohibits the sale of all smoking products with flavors other than tobacco in physical stores. This ban extends to nicotine-free e-liquids and so-called "flavor enhancers", which may include disposable DIY mixtures.


Proposal 31 could even prohibit the Food and Drug Administration (FDA) from authorizing the sale and designation of seasoning products as "suitable for protecting public health" (so far, the FDA has not authorized any seasoning products).


The law also prohibits the sale of flavored nicotine pouches (which are almost always flavored), menthol cigarettes, flavored cigars, and flavored smokeless tobacco, including snuff. The flavor ban does not include hookah products, pipe tobacco, and cigars.


As expected, California is set to become the second state to ban the retail sale of all flavored tobacco and nicotine products, including those that have been granted marketing authorization by the FDA.


I'm sorry to say to smokers in California that they'll find it easier to purchase Marlboro than e-liquids." - Gregory Conley (@GregTHR) November 9, 2022.


The law does not prohibit online sales, but California law mandates that online sales of e-cigarette products – even those originating from out of state – involve a cumbersome process for retailers.


California, along with Massachusetts, is now the only state that has banned the use of flavored tobacco products, including menthol cigarettes and flavored cigars. Three other states, New Jersey, New York, and Rhode Island, have currently banned the use of flavored e-cigarettes (all passed in early 2020), but the sale of menthol cigarettes has not been affected.


Bloomberg's personal expenditure has exceeded the entire tobacco industry's expenditure.


Matthew Myers, the chairman of the Campaign for Tobacco-Free Kids, stated that the passage of Proposal 31 "provides strong momentum for other states and cities, as well as the Food and Drug Administration, to take similar action. The FDA has already proposed rules to ban menthol cigarettes and flavored cigars.


Despite receiving support from almost all national and California public health and tobacco control organizations, as well as California Governor Gavin Newsom (who also won re-election yesterday) and most Democratic politicians, Myers only specifically thanked one person in the organization's press release.


For years, the tobacco industry has been targeting young people and spending billions of dollars promoting flavored products, which are known pathways to lifelong tobacco use. Tobacco remains one of the leading causes of disease and death in the United States. This statement was made by Mike Bloomberg on November 9th, 2022.


We also thank Michael R. Bloomberg for his exceptional leadership in this campaign," Miles said. "No one has done more in combating tobacco use and saving lives around the world.


Former New York City Mayor Bloomberg, who has a net worth of around $77 billion, reportedly donated almost the entire $47 million spent by the organization leading the "Prop 31" campaign to protect the California Children's Trust. According to the East Bay Times, the average American worker would have to work full-time for over 1,900 years to earn the amount of money Bloomberg put towards supporting Proposition 31.


The group "Californians Against Prohibition" who are against this law is nearly entirely funded by tobacco giants, Philip Morris (a subsidiary of the Altria Group) and RJ Reynolds Tobacco Company (a subsidiary of British American Tobacco). These two tobacco companies have each contributed over $9 million, primarily to protect their sales of menthol cigarettes in the largest state in the United States.


Statement:


This article is compiled from third-party information and is intended for industry-related communication and learning.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The translation of this article is intended only for industry research and communication purposes.


As the level of translation may be limited, the translated article may not accurately reflect the original text. It is advised to refer to the original text for accuracy.


2FIRSTS aligns completely with the Chinese government on any domestic, Hong Kong-Macau-Taiwan-related, and foreign-related statements and positions.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Scottish Vape Display Rules Could Cost Businesses £61 Million, Affecting More Than 11,000 Retail Outlets
Scottish Vape Display Rules Could Cost Businesses £61 Million, Affecting More Than 11,000 Retail Outlets
A Scottish government impact assessment estimates that proposed vape display and packaging rules could create up to £61 million ($82 million) in compliance costs for businesses, affecting more than 11,000 retail outlets. The estimated costs are mainly linked to inventory adjustments, retail storage changes and the resources required for businesses to understand and implement the new requirements. The measures form part of the UK’s broader efforts to tighten vape regulation, particularly around product displays, packaging and sales practices.
Aug.10
2Firsts Interview | Cigarette Sales Fall as Smokeless Alternatives Gain in U.S. Convenience Stores, NACS Says
2Firsts Interview | Cigarette Sales Fall as Smokeless Alternatives Gain in U.S. Convenience Stores, NACS Says
Ahead of the 2026 NACS Show, 2Firsts interviewed Chris Rapanick, NACS managing director of research, on changes reshaping the U.S. convenience-store tobacco and nicotine market. NACS data show cigarette sales declining while smokeless alternatives, including nicotine pouches, continue to grow. The interview also examines higher OTP margins, shifting backbar space, weaker store traffic, regulatory uncertainty and NACS’ outlook for 2027, offering a retailer-side view of one of the world’s largest nicotine markets.
Interview
Oct.03
Product | IVG Launches NEXiO Prefilled Pod System, Expanding Beyond Disposable Vapes
Product | IVG Launches NEXiO Prefilled Pod System, Expanding Beyond Disposable Vapes
UK vape brand IVG has launched the NEXiO reusable prefilled pod system, expanding its product portfolio beyond disposable vape products. The device features a 1,000mAh rechargeable battery, prefilled pods with a refill reservoir structure and a claimed capacity of up to 10,000 puffs. Officially launched in the UK on July 9, 2026, NEXiO debuted with 17 flavor options, reflecting IVG’s move into reusable pod formats.
Aug.19
U.S. Customs Plan to Require Foreign Export Declarations Could Deal ‘Devastating’ Blow to China’s Vape Exports, Logistics gl Expert Says
U.S. Customs Plan to Require Foreign Export Declarations Could Deal ‘Devastating’ Blow to China’s Vape Exports, Logistics gl Expert Says
A U.S. Customs and Border Protection proposal to collect foreign export declarations and other overseas customs documents could expose discrepancies in the value, classification and description of China-made vape shipments entering the United States. A veteran Chinese logistics professional told 2Firsts that the measure, if implemented, could undermine the all-inclusive shipping model used by some unauthorized vape exporters and push parts of the trade toward costlier underground channels. The risk extends beyond higher duties: accurately declared products may also be more readily identified as unauthorized e-cigarettes subject to FDA enforcement.
Special Report
Sep.07
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23